Orange Book product · Brand (NDA)
NORPRAMIN
DESIPRAMINE HYDROCHLORIDE
At a glance
Feb 11, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 11, 1982
45 yr ago
Today
Pharmaceutical detail
Active ingredient
DESIPRAMINE HYDROCHLORIDE
Strength
10MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 014399
Product number
007
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —PERTOFRANEBrand (NDA)
NDA 013621 · SANOFI AVENTIS US
- 2021DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209785 · ALEMBIC
- 2017DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 204963 · INGENUS PHARMS LLC
- 2016DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 205153 · ANI PHARMS
- 2016DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 207433 · HERITAGE
- 2016DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208105 · AMNEAL PHARMS CO
- 1996DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 074430 · ACTAVIS TOTOWA
- 1988DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 072103 · CHARTWELL RX
- 1987DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 071803 · ANI PHARMS
- 1987DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 071602 · ACTAVIS TOTOWA
- 1987DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 071766 · ACTAVIS TOTOWA
- 1987DESIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 071864 · USL PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
